239 related articles for article (PubMed ID: 30686699)
21. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
[TBL] [Abstract][Full Text] [Related]
22. Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients.
Kao JE; Zirbes JM; Conrad CK; Milla CE
J Heart Lung Transplant; 2017 Sep; 36(9):980-984. PubMed ID: 28651906
[TBL] [Abstract][Full Text] [Related]
23. A new classification system for chronic lung allograft dysfunction.
Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
[TBL] [Abstract][Full Text] [Related]
24. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
25. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).
Fisher AJ; White M; Goudie N; Kershaw A; Phillipson J; Bardgett M; Lally J; Bevin-Nicholls A; Chadwick T; Bryant A; Russell S; Smith H; Frisby L; Errington R; Carby M; Thompson R; Santhanakrishnan K; Parmar J; Lordan JL; Vale L; Hancock H; Exley C; Gennery AR; Wason JM
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38724453
[TBL] [Abstract][Full Text] [Related]
27. Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients.
Orfanos S; Gomez C; Baron S; Akkisetty R; Dufeu N; Coltey B; Thomas PA; Rolain JM; Reynaud-Gaubert M
BMC Microbiol; 2018 Aug; 18(1):88. PubMed ID: 30126365
[TBL] [Abstract][Full Text] [Related]
28. Ten year follow-up of lung transplantations using initially rejected donor lungs after reconditioning using ex vivo lung perfusion.
Ghaidan H; Fakhro M; Andreasson J; Pierre L; Ingemansson R; Lindstedt S
J Cardiothorac Surg; 2019 Jul; 14(1):125. PubMed ID: 31262311
[TBL] [Abstract][Full Text] [Related]
29. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
30. MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction.
Moher Alsady T; Voskrebenzev A; Greer M; Becker L; Kaireit TF; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
J Magn Reson Imaging; 2019 Dec; 50(6):1873-1882. PubMed ID: 31134705
[TBL] [Abstract][Full Text] [Related]
31. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.
Veraar C; Kliman J; Benazzo A; Oberndorfer F; Laggner M; Hacker P; Raunegger T; Janik S; Jaksch P; Klepetko W; Ankersmit HJ; Moser B
Sci Rep; 2021 Mar; 11(1):6799. PubMed ID: 33762606
[TBL] [Abstract][Full Text] [Related]
32. Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience.
Ruttens D; Martens A; Ordies S; Verleden SE; Neyrinck AP; Vos R; Boada MC; Vanaudenaerde BM; Verleden GM; Van Raemdonck D
Transplantation; 2017 Nov; 101(11):2691-2694. PubMed ID: 28207629
[TBL] [Abstract][Full Text] [Related]
33. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
Calabrese DR; Ekstrand CA; Yellamilli S; Singer JP; Hays SR; Leard LE; Shah RJ; Venado A; Kolaitis NA; Perez A; Combes A; Greenland JR
J Heart Lung Transplant; 2024 Jul; 43(7):1074-1086. PubMed ID: 38367738
[TBL] [Abstract][Full Text] [Related]
34. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
[TBL] [Abstract][Full Text] [Related]
35. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
Vazirani J; Routledge D; Snell GI; Watson D; Paraskeva M; Westall GP; Harrison SJ
Transplant Proc; 2021; 53(1):296-302. PubMed ID: 33039145
[TBL] [Abstract][Full Text] [Related]
36. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.
Corris PA; Ryan VA; Small T; Lordan J; Fisher AJ; Meachery G; Johnson G; Ward C
Thorax; 2015 May; 70(5):442-50. PubMed ID: 25714615
[TBL] [Abstract][Full Text] [Related]
37. Current views on chronic rejection after lung transplantation.
Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
[TBL] [Abstract][Full Text] [Related]
38. Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
Gan CT; Ward C; Meachery G; Lordan JL; Fisher AJ; Corris PA
BMJ Open Respir Res; 2019; 6(1):e000465. PubMed ID: 31673366
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
Snell GI; Levvey BJ; Zheng L; Bailey M; Orsida B; Williams TJ; Kotsimbos TC
J Heart Lung Transplant; 2007 Jul; 26(7):669-74. PubMed ID: 17613395
[TBL] [Abstract][Full Text] [Related]
40. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
Robinson CA; Huber L; Murer C; Schuurmans M; Kohler M; Hofbauer G; Benden C
Swiss Med Wkly; 2017; 147():w14429. PubMed ID: 28488260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
